Roxadustat
ROXAKI
Phase 2 small_molecule terminated
Quick answer
Roxadustat for Coronary Artery Bypass is a Phase 2 program (small_molecule) at Peking University Third Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Peking University Third Hospital
- Indication
- Coronary Artery Bypass
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated